COVID-19 Vaccine Information

Updated 2025-2026 COVID-19 vaccines are available to people 6 months of age and older.

COVID-19 Vaccine Recommendations for Children

American Academy of Pediatrics Immunization Schedule (PDF) recommends updated 2025-2026 COVID-19 vaccines for everyone 6 months – 18 years that target the monovalent JN.1-lineage. The COVID-19 vaccine recommendations for children are as follows:

• Healthy children 6–23 months who are unvaccinated are recommended to receive 2 doses of Moderna Spikevax.
• Healthy children 6–23 months who were previously vaccinated are recommended to receive 1 or 2 doses of Moderna Spikevax (timing and number of doses depends on the previous COVID-19 vaccine[s] received).
• Children 2–4 years at higher risk, regardless of previous vaccination, are recommended to receive 1 dose of Moderna Spikevax at least 2 months after the last dose of any COVID-19 vaccine.
• Children 5–11 years at higher risk, regardless of previous vaccination, are recommended to receive 1 dose of Moderna Spikevax or Pfizer Comirnaty at least 2 months after the most recent dose of any COVID-19 vaccine.
• Children 12–18 years at higher risk, regardless of previous vaccination, are recommended to receive:
  • 1 dose of Moderna Spikevax, Pfizer Comirnaty, or Novavax Nuvaxovid at least 2 months after the most recent dose of any COVID-19 vaccine.
  • 1 dose of Moderna mNEXSPIKE at least 3 months after the most recent dose of any COVID-19 vaccine.

Children 2–18 years not at higher risk whose parent or guardian desires protection from COVID-19 are recommended to receive a single dose of age-appropriate COVID-19 vaccine.

Children 6 months – 18 years who are immunocompromised should talk with their health care provider about the number of doses needed and the timing between doses. 

COVID-19 Vaccine Recommendations for Adults

American Academy of Family Physicians Immunization Schedule (PDF) recommends updated 2025-2026 COVID-19 vaccines for everyone 19 years and older. The COVID-19 vaccine recommendations for adults are as follows:

• Healthy adults 19–64 years who are unvaccinated are recommended to receive 1 dose Moderna Spikevax, mNexspike, Pfizer Comirnaty, or Nuvaxovid.
• Healthy adults 19–64 years who were previously vaccinated are recommended to receive 1 dose Moderna Spikevax, mNexspike, Pfizer Comirnaty, or Nuvaxovid.
• Healthy adults 65 years or older who are unvaccinated or previously vaccinated are recommended to receive 2 doses of Moderna Spikevax, mNexspike, Pfizer Comirnaty, or Nuvaxovid at least 2 months apart.
• Adults 19 years or older who are immunocompromised should talk with their health care provider about the number of doses needed and the timing between doses.